Evidence map›Paper›PMID 29740700›Full record

ArticleClinical research in cardiology : official journal of the German Cardiac Society2018

The best of two worlds? Pulmonary vein isolation using a novel radiofrequency ablation catheter incorporating contact force sensing technology and 56-hole porous tip irrigation.

Tilman Maurer, Laura Rottner, Hisaki Makimoto, Bruno Reissmann, Christian-H Heeger, Christine Lemes, Thomas Fink, Johannes Riedl, Francesco Santoro, Peter Wohlmuth and 6 more

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical research in cardiology : official journal of the German Cardiac Society, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Association between atrial fibrillation and Helicobacter pylori.Clinical research in cardiology : official journal of the German Cardiac Society · 2019
    Pooled it
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Long-term safety and effectiveness of paroxysmal atrial fibrillation ablation using a porous tip contact force-sensing catheter from the SMART SF trial.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2021
    Article
  10. Article
  11. Observational
  12. Association of NT-proBNP and GDF-15 with markers of a prothrombotic state in patients with atrial fibrillation off anticoagulation.Clinical research in cardiology : official journal of the German Cardiac Society · 2020
    Article
  13. Porous tip contact force-sensing catheters for pulmonary vein isolation: performance in a clinical routine setting.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2020
    Article
  14. Article
  15. Left atrial anterior line ablation using ablation index and inter-lesion distance measurement.Clinical research in cardiology : official journal of the German Cardiac Society · 2019
    Article
  16. Remote vs. conventional navigation for catheter ablation of atrial fibrillation: insights from prospective registry data.Clinical research in cardiology : official journal of the German Cardiac Society · 2019
    Article
  17. Exclusion of left atrial thrombus by dual-source cardiac computed tomography prior to catheter ablation for atrial fibrillation.Clinical research in cardiology : official journal of the German Cardiac Society · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Tilman MaurerDepartment of Cardiology, Asklepios Klinik St. Georg, Hamburg, Germany. t.maurer@asklepios.com.
Laura RottnerDepartment of Cardiology, Asklepios Klinik St. Georg, Hamburg, Germany.
Hisaki MakimotoDepartment of Cardiology, Universitätsklinikum Düsseldorf, Düsseldorf, Germany.
Bruno ReissmannDepartment of Cardiology, Asklepios Klinik St. Georg, Hamburg, Germany.
Christian-H HeegerDepartment of Cardiology, Asklepios Klinik St. Georg, Hamburg, Germany.
Christine LemesDepartment of Cardiology, Asklepios Klinik St. Georg, Hamburg, Germany.
Thomas FinkDepartment of Cardiology, Asklepios Klinik St. Georg, Hamburg, Germany.
Johannes RiedlDepartment of Cardiology, Asklepios Klinik St. Georg, Hamburg, Germany.
Francesco SantoroDepartment of Cardiology, Asklepios Klinik St. Georg, Hamburg, Germany.
Peter WohlmuthDepartment of Cardiology, Asklepios Klinik St. Georg, Hamburg, Germany.
Marius VolkmerElectrophysiology Bremen, Heart Center Bremen, Klinikum Links der Weser, Bremen, Germany.
Shibu MathewDepartment of Cardiology, Asklepios Klinik St. Georg, Hamburg, Germany.
Andreas MetznerDepartment of Cardiology, Asklepios Klinik St. Georg, Hamburg, Germany.
Feifan OuyangDepartment of Cardiology, Asklepios Klinik St. Georg, Hamburg, Germany.
Karl-Heinz KuckDepartment of Cardiology, Asklepios Klinik St. Georg, Hamburg, Germany.
Christian SohnsDepartment of Cardiology, Asklepios Klinik St. Georg, Hamburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsThis study aimed to evaluate feasibility and safety as well as 1-year clinical outcome of pulmonary vein isolation (PVI) using a unique radiofrequency ablation catheter ("Thermocool SmartTouch SurroundFlow"; STSF) incorporating both, contact force (CF) sensing technology and enhanced tip irrigation with 56 holes, in one device.

methodsA total of 110 patients suffering from drug-refractory atrial fibrillation underwent wide area circumferential PVI using either the STSF ablation catheter (75 consecutive patients, study group) or a CF catheter with conventional tip irrigation ("Thermocool SmartTouch", 35 consecutive patients, control group). For each ablation lesion, a target CF of ≥ 10-39 g and a force time integral (FTI) of > 400 g s was targeted.

resultsAcute PVI was achieved in all patients with target CF obtained in > 85% of ablation points when using either device. Mean procedure time (131.3 ± 33.7 min in the study group vs. 133.0 ± 42.0 min in the control group; p = 0.99), mean fluoroscopy time (14.0 ± 6 vs. 13.5 ± 6.6 min; p = 0.56) and total ablation time were not significantly different (1751.0 ± 394.0 vs. 1604.6 ± 287.8 s; p = 0.2). However, there was a marked reduction in total irrigation fluid delivery by 51.7% (265.52 ± 64.4 vs. 539.6 ± 118.2 ml; p < 0.01). The Kaplan-Meier estimate 12-month arrhythmia-free survival after the index procedure following a 3-month blanking period was 79.9% (95% CI 70.4%, 90.4%) for the study group and 66.7% for the control group (95% CI 50.2%, 88.5%). This finding did not reach statistical significance (p = 0.18). Major complications occurred in 2/75 patients (2.7%; one pericardial tamponade and one transient ischemic attack) in the study group and no patient in the control group (p = 18).

conclusionPVI using the STSF catheter is safe and effective and results in beneficial 1-year clinical outcome. The improved tip irrigation leads to a significant reduction in procedural fluid burden.

Indexed as

CathetersAgedAtrial FibrillationBody Surface Potential MappingCatheter AblationEquipment DesignFemaleHeart Conduction SystemHeart RateHumansImaging, Three-DimensionalMaleProspective StudiesPulmonary VeinsTherapeutic IrrigationTime FactorsAtrial fibrillationCatheter ablationContact force

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.